A null mutation in the SERPINE1 gene was associated with longer telomeres and increased longevity among carriers, a new study found.
The funding will support research examining the epigenomic effects of social experiences and how they relate to health disparities.
A pair of new studies evaluated whole-exome sequencing and other genetic tests in children with epilepsy and in other undiagnosed monogenic disease cases.
In Cell this week: host-microbe interactions and cancer drug response; links between transcription rate, mRNA translation, and methylation; and more.
In Cell this week: strategies for targeting leukemia with MLL translocations, new Perturb-seq approach, and more.
The team identified gene expression patterns that can determine how severe a patient's systemic sclerosis is and if treatment has been effective.
Guardant360 will be the preferred non-invasive assay for clinical testing of patients at the Lurie Cancer Center, and will be used in various research efforts.
Researchers from Northwestern University uncovered five circulating microRNAs that differentiate patients with very high- and low-risk prostate cancer.
The effort, dubbed the National Resource for Translational and Developmental Proteomics, aims to improve on the technology and train others in its use.
A later change in the protease gene likely enabled the bacterium to cause the invasive infection of bubonic plague.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.